MAY 19, 2021 8:29 AM PDT

Combination Immunotherapy Shows Promise in Treating HIV

WRITTEN BY: Annie Lennon

 

Researchers have found that a new combination immunotherapy, alongside antiretroviral therapy (ART), is effective in controlling and reducing simian immunodeficiency virus (SIV) in animals. The finding, say the researchers, may pave the way for additional treatment options to control HIV/AIDS. 

ART is currently the most common treatment for HIV/AIDS. While it can reduce viral load to undetectable levels, it does not cure the condition. Moreover, ART is often expensive, requires a strict medication regime and is subject to social stigma. As such, researchers are working on alternative treatments for the condition to reduce reliance on ART. 

For the study, the researchers worked with 16 SIV-positive, ART-treated rhesus macaques. In many non-human primates, untreated SIV infections progress into an AIDS-like disease and generate immune cells known as natural killer cells (NK cells) with impaired functionality. 

During the study, the researchers compared animals only treated with ART to those who received ART, Interleukin-21 (IL-21) and interferon-alpha (IFN-alpha) to see how the combination treatment affected the animals’ viral load. 

In the end, the researchers found that ART plus the immunotherapy combo-treated monkeys had improved NK cell responses when compared to those on ART alone. They also noted that the treatment reduced SIV replication in the lymph nodes, an area known to harbor the virus. Being able to target areas where the virus seeks refuge and limiting its ability to replicate, say the researchers, is essential for controlling HIV and preventing its progression into AIDS. 

"This proof-of-concept study in rhesus monkeys, which progress to AIDS-like disease in the absence of ART, demonstrates how certain NK cell activity can contribute to controlling the virus," says Mirko Paiardini, PhD, one of the authors of the study. 

"This opens the door to designing additional treatment strategies to induce SIV and HIV remission in the absence of ART, and, ultimately, reducing the burden HIV is to individuals, families and the world."

 

Sources: Pharmacy TimesNature Communications 

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
MAR 09, 2021
Drug Discovery & Development
Personalized Psychedelic Assisted-Therapy
MAR 09, 2021
Personalized Psychedelic Assisted-Therapy
Psychedelics have long been known for their therapeutic in treating mental health disorders. However, there remains a co ...
MAR 18, 2021
Technology
Technology Fixes Errors Associated with Self-Administering Medications
MAR 18, 2021
Technology Fixes Errors Associated with Self-Administering Medications
Almost all medications allow patients to self-administer—however, that does not mean that they always get it right ...
APR 12, 2021
Drug Discovery & Development
Epidural Use Not Linked To Autism
APR 12, 2021
Epidural Use Not Linked To Autism
Epidurals are a form of pain relief during childbirth and is used by more than half of all women in labor. Many women wh ...
MAY 06, 2021
Drug Discovery & Development
Are Hallucinations Necessary for Psychedelics to Treat Depression?
MAY 06, 2021
Are Hallucinations Necessary for Psychedelics to Treat Depression?
Many who work with psychedelics say that hallucinations, or psychedelic experiences, are an integral part of psychedelic ...
MAY 15, 2021
Drug Discovery & Development
New Drug Blocks Critical Step in Malaria Life Cycle
MAY 15, 2021
New Drug Blocks Critical Step in Malaria Life Cycle
According to the World Health Organization (WHO), in 2019, there were approximately 229 million cases of malaria around ...
JUN 01, 2021
Cannabis Sciences
Can Cannabis Help Manage Symptoms of Multiple Sclerosis?
JUN 01, 2021
Can Cannabis Help Manage Symptoms of Multiple Sclerosis?
As laws around cannabinoids continue to evolve, some people with chronic illnesses such as multiple sclerosis (MS), are ...
Loading Comments...